Literatur
-
1
Conn H O, Leevy C M, Vlahcevic Z R, Rodgers J B. et al .
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double-blind controlled trial.
Gastroenterology.
1977;
72
573-578
-
2
Häussinger D, Steeb R, Gerok W.
Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenic model and therapeutic implications.
Clin Invest.
1992;
70
411-415
-
3
Heemann U, Treichel U, Loock J, Philipp T. et al .
Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study.
Hepatology.
2002;
36
949-958
-
4
Horst D, Grace N D, Conn H O, Schiff E. et al .
Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.
Hepatology.
1984;
4
279-287
-
5
Huber M, Rössle M, Siegerstetter V, Ochs A. et al .
Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
Hepatogastroenterology.
2001;
48
541-544
-
6
Kircheis G, Nilius R, Berndt H, Buchner M. et al .
Therapeutic efficacy of L-ornithine-L-aspartate infusion concentrate in patients with liver cirrhosis and hepatic encephalopathy: A placebo-controlled double-blind study.
Hepatology.
1997;
25
1351-1360
-
7
Kircheis G, Wettstein M, vom Dahl S, Häussinger D.
Clinical efficacy of L-ornithine-L-asparate in the management of hepatic encephalopathy.
Metabolic Brain Disease.
2002;
17
453-462
-
8
Laccetti M, Manes G, Uomo G, Lionello M. et al .
Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.
Dig Liv Dis.
2000;
32
335-338
-
9
Marchesini G, Dioguardi F S, Bianchi G P. et al .
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy.
A randomized double-blind casein-controlled trial J Hepatol.
1990;
11
1-10
-
10
Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M.
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Hepatology.
1996;
23
1084-1092
-
11
Mas A, Rodés J, Sunyer L, Rodrigo L. et al .
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled trial.
J Hepatol.
2003;
38
51-58
-
12
Morgan M Y, Hawley K E.
A randomized double-blind trial of lactitol and lactulose in acute hepatic encephalopathy in cirrhotic patients.
Hepatology.
1987;
7
1278-1284
-
13
Naylor C D, O’Rourke K, Detoky A J, Baker J P.
Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis.
Gastroenterology.
1989;
97
1033-1042
-
14
Stauch S, Kircheis G, Adler G, Beckh K. et al .
L-ornithine-L-aspartate granulate in the treatment of latent and mild chronic hepatic encephalopathy (HE): A placebo-controlled double-blind study.
Journal of Hepatology.
1998;
28
856-864
-
15
Uribe M, Campollo O, Vargas F, Ravelli G P. et al .
Acidifying enemas (lactitol and lactose) versus nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind randomized clinical trial.
Hepatology.
1987;
7
639-643
-
16
Tromm A, Griga T, Greving I, Hilden H. et al .
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
Hepatogastroenterology.
2000;
47
473-477
-
17
Schepke M, Reichel C, Ziske C, Spengler U, Caselmann W H, Sauerbruch T.
Leberzirrhose - Komplikationen und Therapie.
Dtsch Med Wochenschr.
2001;
36
975-984
Prof. Dr. med. Matthias Wettstein
Klinik für Gastroenterologie, Hepatologie und Infektiologie, Universitätsklinikum Düsseldorf
Moorenstraße 5
40225 Düsseldorf
Telefon: 0211/8116330
Fax: 0211/8118752
eMail: wettstein@med.uni-duesseldorf.de
